Predictors of quality of life in chronic obstructive pulmonary disease patients with different frequency of exacerbations

Pakistan Journal of Medical Sciences

Volumn 23, Issue 4, 2007, Pages 490-496

  Ansari, Khalid ^a   Shamssain, M ^a   Keaney, N P ^a   Burns, G ^b   Farrow, M ^c  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Quality of life

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; FEMALE; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL RESEARCH; MUSCLE STRENGTH; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SPIROMETRY;

EID: 34548378745     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BTS guidelines for the management of COPD. The COPD Guidelines Group of the Standard of Care Committee of the BTS. Thorax 1997.
2. Ferrer M, Alonso J, Morera J. Chronic Obstructive Pulmonary disease and health related quality of life. Ann Int Med 1997;127:1072-9.
3. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10):847-52.
4. Miravitlles M, Guerrero T. On behalf of EOLO Study Group. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis. Respiration 2000;67:495-501.
5. Miravitlles M, Alvarez-Sala. JL, Lamarca R. For the IMPACT Study group. Treatment and quality of life in patients with chronic obstructive pulmonary disease. Quality of Life Respiratory J 2002;11:329-38.
6. Seemungal TAR., Donaldson GC, Paul EA. Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease, Am J Respir Crit Care Med 1998;157(5):1418-22.
7. ATS Statement. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease. Amer J Respiratory Critical Care Med 1995;152:1107-36.
8. Jones PW. Measurements of health in asthma and chronic obstructive airway disease. Pharma Med 1992;6:13-22.
9. Ferrer M, Alonso J, Prieto L. Validity and Reliability of the Spanish version of the St. George's Respiratory Questionnaire. Eur Respiratory J 1996;9:1160-6.
10. Mahler DA, Faryniarz K, Tomlinson D, Colice GL, Robins AG. Impact of dyspnoea and physiologic function on general health status in patients with Chronic Obstructive Pulmonary disease. Chest 1992;102(2):395-401.
11. Bestall JC, Paul EA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
12. Ferrer M, Villasante C, Alonso J. Interpretation of quality of life scores from the St.George's Respiratory Questionnaire. Europeon Respiratory J 2002;19(3):405-13.
13. Jenkinson C, Coulter A, Wright L. The Short Form 36(SF 36) Health Survey Questionnaire: Normative Data for adults of working age. BMJ 1993;306(6890):1437-40.
14. Jones PW. A self complete measure of health status for chronic airflow limitation. The SGRQ. American Review of Respiratory Disease 1991;145:1321-7.
15. Juan T, Casanova Ciro. Gender associated difference in determinants of quality of life in patients with COPD: A case study. Health and quality of life outcomes 2006;4:72.
16. Stahl E, Wadbo M, Bengtsson T. Health related quality of life symptoms, exercise capacity and lung function during treatment for moderate to severe COPD. J Outcome Res 2001;5:11-24.
17. Mahler DA. Comparison of Clinical dyspnea ratings and psychophysical measurements of respiratory sensation in chronic airway disease Am Rev Respir Dis 1987;135:1229-33.
18. Wolkove N, Dajczam E. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1996;1251-7.
19. Hajiro T, Nishimura K, Tsukino M, Ikeda A. Stages of disease severity and factors that effect the health status of patients with COPD. Respiratory Medicine 2000;94(9):841-6.
20. Angelis G, Sposato B, Mazzie L. Predictive indices of nocturnal desaturation in COPD patients treated with long term oxygen therapy. Europeon Review of Medical and Pharmacological Sciences 2001;5(5-6):173-99.
21. Bernard S, Blaine P Le, Whittom F. Peripheral Muscle Weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
22. Heikkinen E, Waters WE, Brzezinski ZJ. The elderly in the eleven countries, the socioeconomic survey. Copenhegan: WHO 1993.
23. Katz S, Ford AB, Moskowitz RW. Studies of illness in the aged: The index of ADL: A standardized measure of biological and psychological functions. JAMA 1963;(185):914-9.
24. Gosselink R. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulmonary Rehabilitation 2000;20(6):353-60.
25. Rantanen T. Hand grip strength and cause of total mortality in older disable women. Amer J Geriatric Soc 2003;(51-5):636-41.
26. Sunnerhagen KS. Muscle performance in an urban population sample of 40- to 79-year-old men and women. Scand J Rehab Med 2000;32(4):159-67.
27. Mc Gavin CR, Artvinili H. Dyspnea disability and distance walked, Comparison of estimates of exercise performance in respiratory disease. BMJ 1978;2:241-3.
28. Miravitlles M, Ferrer M. Effect of exacerbation quality of life in patients with chronic obstructive pulmonary disease: A 2 year follows up study. Thorax 2004;59:387-95.
29. Jeanette. The influence of COPD on health related quality of life independent of the influence of comorbidity. J Epidemiology 2003;56:1177-84.
30. Doll H, Grey-Amante P, Duprat-Lomon I, Sagnier PP, Thate-Waschke I, Lorenz J, et al. Quality of life in acute exacerbation of chronic bronchitis: result from a German population study. Respiratory Medicine 2002;96:39-51.